EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Extracellular Vesicles: Emerging Players in Tumor Progression, Diagnosis, and Therapeutic Applications

Lingyu Kong, Wanying Xu iD, Yue Niu, Nan Li, Xingye Fan, Xiaolin Wu, Jiaxuan Wu, Yueqiu Jiang, Yibo Gao, Yi Liu, Tao Yan, Shuang Ma

ACS Biomaterials Science & Engineering · 09.11.2026 · 12 (11) · 5915-5942

DOI: 10.1021/acsbiomaterials.6c00978 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift ACS Biomaterials Science & Engineering, online erschienen am 14.10.2026. Verfasst von Lingyu Kong und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Sports, Shenyang Ligong University, Shenyang110159, China. Hauptthemen laut MEDLINE: Extracellular Vesicles, Neoplasms. Die Arbeit nennt 139 Literaturangaben. Gefördert von: The Applied Basic Fund of Liaoning Province, Liaoning Provincial Natural Science Foundation Doctoral Research Launch Project, Basic Research Project of Liaoning Provincial Department of Education.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Extracellular vesicles (EVs) are emerging as critical players in oncology and also exert vital regulatory effects on exercise-induced muscle injury repair, offering novel insights into tumor biology. Tumor-derived EVs facilitate intercellular communication by carrying bioactive molecules such as proteins and nucleic acids, which reshape the tumor microenvironment and enhance tumor invasion, metastasis, and drug resistance. Conversely, specific subsets of EVs, particularly those derived from dendritic cells or engineered to present tumor antigens, can elicit antitumor immune responses by activating cytotoxic T lymphocytes and facilitating antigen cross-presentation. Clinically, the high stability of EVs in body fluids, coupled with their intrinsic capacity to encapsulate and protect tumor-derived molecular cargo, positions them as robust noninvasive biomarkers for early cancer diagnosis and prognostic stratification, as well as indicators for evaluating muscle recovery status after exercise. Additionally, EVs function as drug delivery carriers, offering advantages like biocompatibility, low immunogenicity, and targeting capabilities. However, challenges remain in EVs isolation, characterization, and scalable production, with inconsistent techniques affecting purity, structure, and biological activity. Moreover, limited understanding of EVs mechanisms, such as their role in immune modulation and drug delivery efficiency, hinders broader clinical translation across oncology and musculoskeletal rehabilitation. Addressing these issues requires advances in standardization, scalable manufacturing, and extensive clinical trials to ensure its safety and efficacy. Despite these challenges, EVs hold immense promise as transformative tools in precision oncology and sports rehabilitation, paving the way for innovative diagnostics, therapies, and improving patient and athletic outcomes in the fight against cancer and exercise-related muscle damage.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular VesiclesNeoplasmsHumansAnimalsTumor MicroenvironmentDisease ProgressionBiomarkers, TumorDrug Delivery Systems

Stichwörter der Autor:innen

drug deliveryextracellular vesiclesimmunotherapyliquid biopsytumor microenvironment

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • School of Sports, Shenyang Ligong University, Shenyang110159, China.
  • School of Information Science and Engineering, Shenyang Ligong University, Shenyang110159, China.
  • School of Mathematics and Statistics, Liaoning University, Shenyang110036, China.
  • Department of Oral and Maxillofacial Surgery, Taikang Bybo Dental, Beijing100062, China.
  • Department of Anesthesiology, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan030013, Ch…
  • Department of Anesthesiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing100021, China.

ORCID-Profile: Wanying Xu

Förderung

  • The Applied Basic Fund of Liaoning Province
  • Liaoning Provincial Natural Science Foundation Doctoral Research Launch Project
  • Basic Research Project of Liaoning Provincial Department of Education

Zitieren

APA

Kong, L., Xu, W., Niu, Y., Li, N., Fan, X., Wu, X., Wu, J., Jiang, Y., Gao, Y., Liu, Y., Yan, T., & Ma, S. (2026). Extracellular Vesicles: Emerging Players in Tumor Progression, Diagnosis, and Therapeutic Applications. ACS Biomaterials Science & Engineering, 12(11), 5915-5942. https://doi.org/10.1021/acsbiomaterials.6c00978

Vancouver

Kong L, Xu W, Niu Y, Li N, Fan X, Wu X, et al. Extracellular Vesicles: Emerging Players in Tumor Progression, Diagnosis, and Therapeutic Applications. ACS Biomaterials Science & Engineering. 2026;12(11):5915-5942. doi:10.1021/acsbiomaterials.6c00978

BibTeX
@article{Kong2026,
  author = {Kong, Lingyu and Xu, Wanying and Niu, Yue and Li, Nan and Fan, Xingye and Wu, Xiaolin and Wu, Jiaxuan and Jiang, Yueqiu and Gao, Yibo and Liu, Yi and Yan, Tao and Ma, Shuang},
  title = {Extracellular Vesicles: Emerging Players in Tumor Progression, Diagnosis, and Therapeutic Applications},
  journal = {ACS Biomaterials Science & Engineering},
  year = {2026},
  volume = {12},
  number = {11},
  pages = {5915--5942},
  doi = {10.1021/acsbiomaterials.6c00978}
}
Kostenlos starten →